PSG9 and breast carcinoma: To determine the functional role of PSG9 in breast cancer progression, we first examined PSG9 expression levels by immunoblotting in normal HMEC and multiple breast cancer cell lines, including HCC1806, HCC1937, SUM159, Hs578T, MDA‐MB‐453 (MDA‐453), and BT549.